Insights

Why cGMP Matters

IS YOUR COMPANY cGMP 210/211 COMPLIANT?   A couple of years ago, a friend asked me to teach him how to make cannabidiol (CBD) isolate. A few days later I drove into the country and found him in an actual (and proverbial) barn – dirt floor, tobacco boxes, and threshers from the 1950s. My friend […]

Why cGMP Matters Read More »

NEWS: Averix Bio Launches Largest Industrial Hemp Research, Extraction and Production Campus in Eastern U.S.

AVERIX BIO LAUNCHES LARGEST CANNABINOID RESEARCH, EXTRACTION AND PRODUCTION CAMPUS IN EASTERN U.S. North Carolina-based company produces pharma- and food-grade CBD ingredients backed by AI-powered blockchain technology Wilson, N.C., (Oct. 13, 2020) — Averix Bio officially launched its 200,000-square-foot industrial hemp research and extraction facility in North Carolina’s Research Triangle region this week. Designed for full cGMP

NEWS: Averix Bio Launches Largest Industrial Hemp Research, Extraction and Production Campus in Eastern U.S. Read More »

The Q Word: What Does Quality Mean at Averix Bio?

THE Q WORD: WHAT DOES QUALITY MEAN AT AVERIX BIO? Today we’re talking with Will Corbitt, our Vice President of Quality and Compliance. Will is our pharmaceutical quality control and compliance guru with 46+ years in the business. He’s worked for companies large and small, including multinational companies like Burroughs Wellcome, GSK, Pfizer, Novartis, Roche,

The Q Word: What Does Quality Mean at Averix Bio? Read More »

The FDA and Cannabinoids: An Overview of Regulatory History in the U.S.

The FDA and Cannabinoids: An Overview of Regulatory History in the U.S. At Averix Bio, we believe increased FDA regulation is necessary to ensure the safety and long-term viability of this industry.   Cannabis-derived remedies have been used for centuries The use of the Cannabis sativa plant for medicinal and other purposes has been around

The FDA and Cannabinoids: An Overview of Regulatory History in the U.S. Read More »